Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1972 1
1978 1
1986 1
1989 2
1990 1
1991 2
1992 3
1993 3
1994 1
1995 1
1996 4
1997 1
1998 4
1999 1
2000 1
2001 1
2002 5
2004 5
2005 6
2006 10
2007 12
2008 3
2009 8
2010 11
2011 7
2012 6
2013 9
2014 10
2015 13
2016 10
2017 16
2018 13
2019 8
2020 23
2021 18
2022 24
2023 18
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

238 results

Results by year

Filters applied: . Clear all
Page 1
New-onset autoimmune phenomena post-COVID-19 vaccination.
Chen Y, Xu Z, Wang P, Li XM, Shuai ZW, Ye DQ, Pan HF. Chen Y, et al. Immunology. 2022 Apr;165(4):386-401. doi: 10.1111/imm.13443. Epub 2022 Jan 7. Immunology. 2022. PMID: 34957554 Free article. Review.
Vaccination programmes are being rolled out globally, but most of these vaccines have been approved without extensive studies on their side-effects and efficacy. ...In fact, we do not aim to disavow the overwhelming benefits of mass COVID-19 vaccination in pr …
Vaccination programmes are being rolled out globally, but most of these vaccines have been approved without extensive studies …
Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape.
Tregoning JS, Flight KE, Higham SL, Wang Z, Pierce BF. Tregoning JS, et al. Nat Rev Immunol. 2021 Oct;21(10):626-636. doi: 10.1038/s41577-021-00592-1. Epub 2021 Aug 9. Nat Rev Immunol. 2021. PMID: 34373623 Free PMC article. Review.
Where 2020 saw the development and testing of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at an unprecedented pace, the first half of 2021 has seen vaccine rollout in many countries. In this Progress article, we provide a snapshot o …
Where 2020 saw the development and testing of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at an unp …
Dendritic cells in cancer immunology and immunotherapy.
Wculek SK, Cueto FJ, Mujal AM, Melero I, Krummel MF, Sancho D. Wculek SK, et al. Nat Rev Immunol. 2020 Jan;20(1):7-24. doi: 10.1038/s41577-019-0210-z. Epub 2019 Aug 29. Nat Rev Immunol. 2020. PMID: 31467405 Review.
Many strategies have been developed to target DCs in cancer, such as the administration of antigens with immunomodulators that mobilize and activate endogenous DCs, as well as the generation of DC-based vaccines. A better understanding of the diversity and functions of DC …
Many strategies have been developed to target DCs in cancer, such as the administration of antigens with immunomodulators that mobilize and …
Allergen immunotherapy: past, present and future.
Durham SR, Shamji MH. Durham SR, et al. Nat Rev Immunol. 2023 May;23(5):317-328. doi: 10.1038/s41577-022-00786-1. Epub 2022 Oct 17. Nat Rev Immunol. 2023. PMID: 36253555 Free PMC article. Review.
Allergen immunotherapy is a form of therapeutic vaccination for established IgE-mediated hypersensitivity to common allergen sources such as pollens, house dust mites and the venom of stinging insects. ...Oral immunotherapy for peanut allergy induces effective 'desensitiza …
Allergen immunotherapy is a form of therapeutic vaccination for established IgE-mediated hypersensitivity to common allergen sources …
A guide to cancer immunotherapy: from T cell basic science to clinical practice.
Waldman AD, Fritz JM, Lenardo MJ. Waldman AD, et al. Nat Rev Immunol. 2020 Nov;20(11):651-668. doi: 10.1038/s41577-020-0306-5. Epub 2020 May 20. Nat Rev Immunol. 2020. PMID: 32433532 Free PMC article. Review.
This area of immunological research has been highly active for the past 50 years and is now enjoying unprecedented bench-to-bedside clinical success. Here, we provide a comprehensive historical and biological perspective regarding the advent and clinical implementat …
This area of immunological research has been highly active for the past 50 years and is now enjoying unprecedented bench-to-bedside clini …
Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies.
Haynes BF, Wiehe K, Borrow P, Saunders KO, Korber B, Wagh K, McMichael AJ, Kelsoe G, Hahn BH, Alt F, Shaw GM. Haynes BF, et al. Nat Rev Immunol. 2023 Mar;23(3):142-158. doi: 10.1038/s41577-022-00753-w. Epub 2022 Aug 12. Nat Rev Immunol. 2023. PMID: 35962033 Free PMC article. Review.
After nearly four decades of research, a safe and effective HIV-1 vaccine remains elusive. There are many reasons why the development of a potent and durable HIV-1 vaccine is challenging, including the extraordinary genetic diversity of HIV-1 and its complex mechani …
After nearly four decades of research, a safe and effective HIV-1 vaccine remains elusive. There are many reasons why the development …
Viral targets for vaccines against COVID-19.
Dai L, Gao GF. Dai L, et al. Nat Rev Immunol. 2021 Feb;21(2):73-82. doi: 10.1038/s41577-020-00480-0. Epub 2020 Dec 18. Nat Rev Immunol. 2021. PMID: 33340022 Free PMC article. Review.
Vaccines are urgently needed to control the coronavirus disease 2019 (COVID-19) pandemic and to help the return to pre-pandemic normalcy. A great many vaccine candidates are being developed, several of which have completed late-stage clinical trials and are r …
Vaccines are urgently needed to control the coronavirus disease 2019 (COVID-19) pandemic and to help the return to pre-pandemic norma …
The roles of extracellular vesicles in the immune system.
Buzas EI. Buzas EI. Nat Rev Immunol. 2023 Apr;23(4):236-250. doi: 10.1038/s41577-022-00763-8. Epub 2022 Aug 4. Nat Rev Immunol. 2023. PMID: 35927511 Free PMC article. Review.
It ends with a focus on the relevance of EVs to immunotherapy and vaccination, drawing attention to ongoing or recently completed clinical trials that aim to harness the therapeutic potential of EVs....
It ends with a focus on the relevance of EVs to immunotherapy and vaccination, drawing attention to ongoing or recently completed …
Advancing an HIV vaccine; advancing vaccinology.
Burton DR. Burton DR. Nat Rev Immunol. 2019 Feb;19(2):77-78. doi: 10.1038/s41577-018-0103-6. Nat Rev Immunol. 2019. PMID: 30560910 Free PMC article. Review.
Of any pathogen, HIV provides perhaps the greatest challenge to successful vaccine development. Nevertheless, progress continued to be made in 2018; new vaccine concepts entered the clinic and new insights were obtained in basic research that will ultimately …
Of any pathogen, HIV provides perhaps the greatest challenge to successful vaccine development. Nevertheless, progress continued to b …
Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses.
Chen Y, Zhao X, Zhou H, Zhu H, Jiang S, Wang P. Chen Y, et al. Nat Rev Immunol. 2023 Mar;23(3):189-199. doi: 10.1038/s41577-022-00784-3. Epub 2022 Sep 27. Nat Rev Immunol. 2023. PMID: 36168054 Free PMC article. Review.
The ongoing COVID-19 pandemic caused by SARS-CoV-2 has caused serious damage to public health and the global economy, and one strategy to combat COVID-19 has been the development of broadly neutralizing antibodies for prophylactic and therapeutic use. Many are in preclinical and …
The ongoing COVID-19 pandemic caused by SARS-CoV-2 has caused serious damage to public health and the global economy, and one strategy to co …
238 results